Interstitial Pneumonitis after Treatment with Pemetrexed for Non-small Cell Lung Cancer

Pemetrexed is approved as a first-line treatment for advanced non-squamous non-small cell lung cancer (NSCLC) with cisplatin and as a single agent for second-line treatment or for patients who show no disease progression after four cycles of platinum-based doublet induction chemotherapy as maintenan...

詳細記述

保存先:
書誌詳細
主要な著者: Kim, Kyeong-Hyun, Song, Seo-Young, Lim, Kyu-Hyoung, Han, Seon-Sook, Kim, Se-Hyun, Cho, Jun Hwi, Park, Chan Woo, Lee, Seoungkoo, Lee, Hui-Young
フォーマット: Artigo
言語:Inglês
出版事項: Korean Cancer Association 2013
主題:
Case Report
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC3629367/
https://ncbi.nlm.nih.gov/pubmed/23613674
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4143/crt.2013.45.1.74
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料